Nuclear medicine start-up International Isotopes has won a major contract that will help the company in its quest to become a supplier of medical radioisotopes (SCAN 9/3/97). The company has signed a deal to provide its radioactive seeds to Imagyn
Nuclear medicine start-up International Isotopes has won a major contract that will help the company in its quest to become a supplier of medical radioisotopes (SCAN 9/3/97). The company has signed a deal to provide its radioactive seeds to Imagyn Medical Technologies, which will have exclusive worldwide rights to market the seeds for brachytherapy prostate cancer treatment, according to Newport Beach, CA-based Imagyn.
International Isotopes, of Denton, TX, will develop and manufacture the radioactive seeds for distribution through Imagyn's direct sales force. Imagyn will pay International Isotopes $1 million to develop the seeds and has agreed to purchase seeds for three years. Imagyn anticipates that it will file a 510(k) application for the company's initial brachytherapy product, iodine-125, with the Food and Drug Administration by March 31.
In other Imagyn news, the company has announced that it will close its Laguna Niguel, CA, plant and move its endoscope manufacturing facility to Costa Mesa, CA. As part of its consolidation, the firm is reducing its work force by about 120 people.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.